Enhancing effect of daidzein on the differentiation and mineralization in mouse osteoblast-like MC3T3-E1 cells.

The effect of daidzein, an important isoflavone, on the differentiation and mineralization in MC3T3-E1 cells, a mouse calvaria osteoblast-like cell line, was investigated. The MTT assay, the alizarin red S and von Kossa staining, the measurement of calcium (Ca) and phosphorus (P) concentrations by inductively coupled plasma-atomic emission spectrometry and the nitrophenol liberation method were used to determine the cell proliferation, mineralization and intracellular alkaline phosphatase (ALP) activity, respectively. Daidzein enhanced the cell proliferation after the culture for 2 days and the effect reached maximum on day 6. ALP activity and cellular Ca and P contents were increased time- and dose-dependently when the cells were treated with daidzein in the presence of disodium beta-glycerophosphate and L-ascorbic acid. Differentiation of the cells to the mature osteoblasts was prompted under incubation in the presence of daidzein for 21 days, by the time the mineralized nodules formed. The calcium depositions of the cells by alizarin red S staining were increased significantly after the culture with daidzein as long as 28 days. It has been demonstrated that daidzein may be able to enhance the bone differentiation and mineralization and prompt the bone formation in the early growing stage and the late growing stage of osteoblasts.

[1]  M. Lieberherr,et al.  A low dose of daidzein acts as an ERβ‐selective agonist in trabecular osteoblasts of young female piglets , 2004, Journal of cellular physiology.

[2]  T. Jia,et al.  Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. , 2003, Biochemical pharmacology.

[3]  S. C. Garner,et al.  Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. , 2002, Biochemical and biophysical research communications.

[4]  M. Lieberherr,et al.  Down‐Regulation of Osteoclast Differentiation by Daidzein via Caspase 3 , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  Brenda J. Smith,et al.  Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action. , 2002, The Journal of nutritional biochemistry.

[6]  A. Sood,et al.  Hormone replacement therapy and cancer risk , 2001, Current opinion in oncology.

[7]  I. Persson Estrogens in the causation of breast, endometrial and ovarian cancers — evidence and hypotheses from epidemiological findings , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  M. Yamaguchi,et al.  Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: Activation of aminoacyl-tRNA synthetase , 2000, Molecular and Cellular Biochemistry.

[9]  G. Mundy Pathogenesis of osteoporosis and challenges for drug delivery. , 2000, Advanced drug delivery reviews.

[10]  M. Yamaguchi,et al.  Stimulatory effect of Daidzein in osteoblastic MC3T3-E1 cells. , 2000, Biochemical pharmacology.

[11]  M. Yamaguchi,et al.  Anabolic effect of daidzein on cortical bone in tissue culture: Comparison with genistein effect , 1999, Molecular and Cellular Biochemistry.

[12]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[13]  R. Prince,et al.  Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. , 1997, The Journal of nutrition.

[14]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[15]  G. Stein,et al.  Relationship of cell growth to the regulation of tissue‐specific gene expression during osteoblast differentiation , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  A. Parfitt Bone remodeling and bone loss: understanding the pathophysiology of osteoporosis. , 1987, Clinical obstetrics and gynecology.